CID 154618785

Ritivixibat

Structural Information

Molecular Formula
C26H36N2O5S2
SMILES
CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)N1)OCCC(=O)O)SC)C3=CC=CC=C3)CCCC
InChI
InChI=1S/C26H36N2O5S2/c1-4-6-14-26(15-7-5-2)19-28(20-11-9-8-10-12-20)21-17-23(34-3)22(33-16-13-25(29)30)18-24(21)35(31,32)27-26/h8-12,17-18,27H,4-7,13-16,19H2,1-3H3,(H,29,30)
InChIKey
XHOVXESPVIUTMC-UHFFFAOYSA-N
Compound name
3-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,2,5-benzothiadiazepin-8-yl)oxy]propanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

22
Patents

520.20654 Da
Monoisotopic Mass

5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 521.21382 218.7
[M+Na]+ 543.19576 221.0
[M-H]- 519.19926 219.3
[M+NH4]+ 538.24036 225.1
[M+K]+ 559.16970 219.1
[M+H-H2O]+ 503.20380 210.3
[M+HCOO]- 565.20474 220.1
[M+CH3COO]- 579.22039 236.1
[M+Na-2H]- 541.18121 217.3
[M]+ 520.20599 221.4
[M]- 520.20709 221.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe